Stage Iiia Cardiac Al Amyloidosis clinical trials

Explore recruiting stage iiia cardiac al amyloidosis clinical trials.

Also recruiting in Europe

Stage Iiia Cardiac Al Amyloidosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of CAEL-101 and Plasma Cell Dyscrasia Treatment Versus Placebo and Plasma Cell Dyscrasia Treatment in Plasma Cell Dyscrasia Treatment-Naïve Patients with Mayo Stage IIIa AL Amyloidosis

Spain, Germany, Czechia, Poland, Greece, Austria +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Stage Iiia Cardiac Al Amyloidosis trials by city

Stage Iiia Cardiac Al Amyloidosis in Toronto Stage Iiia Cardiac Al Amyloidosis in Vancouver Stage Iiia Cardiac Al Amyloidosis in Montreal Stage Iiia Cardiac Al Amyloidosis in Calgary Stage Iiia Cardiac Al Amyloidosis in Edmonton Stage Iiia Cardiac Al Amyloidosis in Ottawa Stage Iiia Cardiac Al Amyloidosis in Winnipeg Stage Iiia Cardiac Al Amyloidosis in Quebec City Stage Iiia Cardiac Al Amyloidosis in Hamilton Stage Iiia Cardiac Al Amyloidosis in Kitchener Stage Iiia Cardiac Al Amyloidosis in London Stage Iiia Cardiac Al Amyloidosis in Halifax Stage Iiia Cardiac Al Amyloidosis in New York Stage Iiia Cardiac Al Amyloidosis in Los Angeles Stage Iiia Cardiac Al Amyloidosis in Chicago Stage Iiia Cardiac Al Amyloidosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease